The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Pacific Biosciences of California Inc (NASDAQ: PACB) was $1.19 for the day, down -6.30%% from the previous closing price of $1.27. In other words, the price has decreased by -$6.30% from its previous closing price. On the day, 8.0 million shares were traded. PACB stock price reached its highest trading level at $1.27 during the session, while it also had its lowest trading level at $1.16.
Ratios:
Our analysis of PACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.87 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 7.63 whereas as Long-Term Debt/Eq ratio is at 7.60.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 19 ’25 when Farmer Michele sold 5,195 shares for $1.00 per share. The transaction valued at 5,200 led to the insider holds 269,259 shares of the business.
HENRY CHRISTIAN O sold 12,497 shares of PACB for $17,583 on Mar 03 ’25. The insider now owns 2,225,357 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Van Oene Mark, who serves as the insider of the company, sold 6,486 shares for $1.41 each. As a result, the insider received 9,126 and left with 1,497,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 357101152 and an Enterprise Value of 716101760. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.34 while its Price-to-Book (P/B) ratio in mrq is 3.90. Its current Enterprise Value per Revenue stands at 4.7 whereas that against EBITDA is -2.993.
Stock Price History:
The Beta on a monthly basis for PACB is 2.09, which has changed by -0.14999998 over the last 52 weeks, in comparison to a change of 0.10163462 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 5.20%, while the 200-Day Moving Average is calculated to be -24.46%.
Shares Statistics:
PACB traded an average of 8.88M shares per day over the past three months and 10012530 shares per day over the past ten days. A total of 300.04M shares are outstanding, with a floating share count of 264.16M. Insiders hold about 11.97% of the company’s shares, while institutions hold 65.75% stake in the company. Shares short for PACB as of 1748563200 were 52016090 with a Short Ratio of 5.86, compared to 1745971200 on 49206267. Therefore, it implies a Short% of Shares Outstanding of 52016090 and a Short% of Float of 19.73.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
